SPECTRUM PHARMATECH CONSULTANTS - NEW COMPANY PROFILE
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
20<br />
CELEBRATING<br />
Company Profile<br />
Think... Challenge...Explore...Create...Exceed...
Contents<br />
About Us 1<br />
Field of Expertise 4<br />
Our Capabilities 5<br />
Our Clients 7<br />
Case Studies 11<br />
Project Coverage 13
ABOUT US<br />
<strong>SPECTRUM</strong> PharmaTECH Consultants Pvt. Ltd. (<strong>SPECTRUM</strong>) is a<br />
knowledge based, fully integrated Architectural and Engineering firm<br />
providing state of art solutions to clients in the pharmaceutical, biotech,<br />
food, beverage and cosmetic industries worldwide, satisfying the strictest<br />
regulatory requirements.<br />
Started in 1995, <strong>SPECTRUM</strong> has been offering one-stop Engineering<br />
Solutions to APIs, Finished Dosage Forms (OSD, Semi Solids, and Aseptic<br />
Products.), Analytical and Microbiological Laboratories, Pilot Plants, R&D<br />
Centres, High Potent Products, Herbal Medicines, Cosmetics etc.<br />
.<br />
VISION:<br />
To be a leading Architectural and Engineering Consultant<br />
providing integrated services from Laboratory to Consumer.<br />
To achieve our vision we will strive to:<br />
<br />
<br />
<br />
Provide reliable professional services to our clients<br />
Forge mutually beneficial and lasting relationships with our clients and<br />
partners<br />
Develop our staff to deliver the highest quality of service and to seek<br />
innovative and creative approaches to problem solving.<br />
1<br />
<strong>SPECTRUM</strong> employs more than 80 technical professionals and offers a<br />
broad range of highly experienced and motivated engineers with hands on<br />
experience and technical expertise in their chosen domains.<br />
With a strong history of innovation and technological advancement, our<br />
experts seek out not only the most up to date equipment but also the most<br />
logical solutions for our clients.<br />
<strong>SPECTRUM</strong>'s designs are based on foresight and experience, resulting in GMP<br />
compliance by design.
Advantage <strong>SPECTRUM</strong><br />
<strong>SPECTRUM</strong> has a track record of working with leading Indian and Multinational clients. One can count on <strong>SPECTRUM</strong><br />
to deliver quality advice based on a thorough market research, current trends and future scenario; the best and most<br />
practical designs; track schedules and monitor construction to produce the most suitable, cost effective solutions within<br />
fixed time-lines.<br />
Single Source Reliability<br />
You can count on <strong>SPECTRUM</strong> to deliver quality designs, track schedules &<br />
monitor construction as an agent on your behalf.<br />
Single source responsibility means the firm will fix a problem when it shows<br />
up. Spectrum provides Single Point Reliability, which means that we will<br />
avoid having most of those problems in the first place.<br />
ETHICS:<br />
<strong>SPECTRUM</strong> lays great emphasis on ethics and honesty. What<br />
you get is a fair, unbiased and objective appraisal of the<br />
market.<br />
Commitment<br />
<strong>SPECTRUM</strong> is committed to providing their clients with the highest possible level of architectural, planning, design,<br />
engineering and validation services.<br />
Our Quality policy<br />
Ensuring customer satisfaction through leadership in engineering, technology and management services.<br />
Spectrum is committed to understand, meet and when possible exceed our Customer's expectations through continuous<br />
improvement of our working methods, systems and processes. We are dedicated to delivering defect-free services to all<br />
our customers on time - every time.<br />
Passion for excellence, obsession with customer satisfaction, integrity in our commitments and mutual respect in our day to<br />
day working guide us to fulfilling this.<br />
2
Sustainability<br />
<strong>SPECTRUM</strong> gives prime importance to energy efficient designs and undertakes strict measures to protect the<br />
environment. All our designs by policy are zero discharge facilities (unless specifically requested otherwise) that use all<br />
the waste water generated on site for internal usage.<br />
We take design decisions that help in consumption of optimum energy required only and no more.<br />
We also recognize that land is the most valuable asset today. We ensure during the conceptualization stage itself that we<br />
optimize its usage and always strive for ability to expand in future.<br />
Our Approach<br />
At <strong>SPECTRUM</strong> we have embraced the Project Cycle<br />
Approach. We participate and guide the Client through<br />
the project life cycle from concept design, basic and<br />
detailed engineering, undertake project management<br />
along with construction supervision to validation and<br />
start-up of the facility.<br />
We believe that as consultants we are but an extension<br />
of our clients. Each of our project team members not<br />
only aim but achieve client satisfaction.<br />
Hand<br />
Over<br />
Commissioning<br />
&<br />
Qualification<br />
Construction<br />
Procurement Assistance<br />
Basic & Detailed Engineering Design<br />
Concept Design and Master Planning<br />
You & We<br />
WE HELP YOU TO CONVERT<br />
YOUR PLANS FOR TODAY INTO<br />
A BETTER<br />
TOMORROW<br />
We recognize that our team is not the largest<br />
that you will come across, but we also know<br />
that you will be hard pressed to find a team<br />
more agile, responsive and flexible enough to<br />
accommodate your needs. We are engaged,<br />
c o m m u n i c a t i v e , c o l l a b o r a t i v e a n d<br />
committed.<br />
After all we are an extension of you.<br />
3
Field Of Expertise<br />
INDUSTRIES<br />
SERVED<br />
We provide complete project<br />
engineering services from concept<br />
to commissioning with in-house<br />
expertise for architectural, civil,<br />
structural, mechanical, HVAC,<br />
piping, water treatment, electrical,<br />
effluent treatment and fire and<br />
safety systems.<br />
We Follow<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
®<br />
Baseline Engineering guides published by ISPE<br />
ISO 14644 – Design of Clean Room & Associated<br />
Controlled Environments<br />
US FDA<br />
UK MHRA<br />
SOUTH AFRICAN MCC<br />
AUSTRALIAN TGA<br />
INDIAN SCHEDULE – M<br />
BRAZILIAN ANVISA<br />
WHO GMP<br />
DESIGN<br />
APPROACH<br />
FlexibleandComprehensive<br />
EnvironmentProtection<br />
SafetybyDesign<br />
CostEffectiveSolutions<br />
CustomizedEngineering<br />
UnderstandtheClient’sRequirements<br />
4
Our Capabilities<br />
We provide complete project engineering services from concept to commissioning with in-house expertise for<br />
architectural, civil, structural, mechanical, HVAC, piping and electrical engineering services. We are known in the<br />
Pharmaceutical Industry for the services we undertake including:<br />
Advisory/<br />
Master Planning<br />
Basis of<br />
Design<br />
Development<br />
Engineering<br />
Construction<br />
Qualification<br />
&<br />
Validation<br />
Pre-feasibility &<br />
Feasibility studies<br />
Master Planning &<br />
Conceptual design<br />
Site selection studies<br />
Tenant Search<br />
Benchmarking<br />
EU-GMP / FDA<br />
consulting<br />
Due Diligence &<br />
Audits<br />
General Planning or<br />
Engineering<br />
Technology<br />
Research<br />
Equipment Study &<br />
Procurement<br />
Design Development<br />
Civil & Architecture<br />
Expansion/Relocatio<br />
n/ Integration<br />
Planning<br />
Detailed Building<br />
Engineering including<br />
Architectural<br />
Civil<br />
Structural<br />
Process<br />
HVAC<br />
Electrical<br />
Mechanical & Piping<br />
Utilities<br />
Plumbing<br />
Instrumentation &<br />
Automation<br />
Fire & Safety<br />
Environmental<br />
Inter - Disciplinary<br />
Construction and<br />
Project<br />
Management<br />
Site management<br />
Construction<br />
Supervision<br />
Procurement<br />
Time Cost<br />
Estimation<br />
Bill Certification<br />
DQ / IQ / OQ<br />
GMP Risk analysis<br />
Computer system<br />
validation<br />
Cleaning validation<br />
Support services for<br />
process validation<br />
Validation<br />
Documentation<br />
From the very level of conceptualizing, <strong>SPECTRUM</strong> participates with and guides the Client through the project life cycle<br />
including assessment of project feasibility, master planning, architectural design, detailed engineering, risk and hazard<br />
assessment, construction management to validation and start up.<br />
We have a track of earning projects repetitively from world renowned national and international manufacturers like<br />
Glenmark, Dr. Reddy's, Johnson & Johnson, RPG Life Sciences, Sanzyme, OmniActive, Novartis etc. This is a testimony<br />
to the quality of service provided by us.<br />
5
End To End Solutions for Your Business<br />
<strong>SPECTRUM</strong> along with their<br />
associates offers its clients endto-end<br />
healthcare business<br />
solutions enabling you to surpass<br />
the short term as well as long term<br />
goals.<br />
Turnkey<br />
setting up<br />
State-of-the-art<br />
cGMP compliant<br />
facilities to<br />
manufacture the<br />
selected<br />
products.<br />
<br />
Technology<br />
Identify<br />
partners for<br />
sourcing of<br />
Techonology,<br />
APIs, Intermediates,<br />
Packaging material<br />
and Finished<br />
Products.<br />
Product Portfolio<br />
building by<br />
identifying right<br />
products with focus<br />
on growing therapy<br />
segments and<br />
molecules.<br />
End To End<br />
Solutions<br />
Recruitment<br />
Support<br />
recruitment of<br />
personnel for<br />
Operations.<br />
Market Potential<br />
Study for<br />
Domestic Sale &<br />
Exports.<br />
Weareproudofourability<br />
tocreateanddeliver<br />
bettersolutionstoourclients<br />
24<br />
6
Key Clients: International<br />
Acme, Bangladesh<br />
Beximco Pharmaceu cals,<br />
Bangladesh<br />
Ethiopian Pharmaceu cal<br />
Manufacturing (EPHARM), Ethiopia<br />
Geltech, Dubai<br />
Glenmark Pharmaceu cals, Brazil<br />
Glenmark Generics, Argen na<br />
Jizhong Pharma, China<br />
Pharmasyntez, Russia<br />
East Pharm, Russia<br />
Kusum Pharm, Ukraine<br />
Neapolis Laboratories, Tunisia<br />
Letap Pharmaceu cals, Ghana<br />
Medica Pharmaceu cals, Yemen<br />
Novast Laboratories, China<br />
Pharmax Pharmaceu cals, Dubai<br />
Polygon FZC, Turkmenistan<br />
Swiss Biogenics, Sri Lanka<br />
Ultra Pharma, Bangladesh<br />
A J Biologics, Malaysia<br />
BDA Life Science, Congo<br />
BIEM ILAC, Turkey<br />
7
Key Clients: Finished Dosage Forms<br />
Apex Laboratories<br />
Aurobindo Pharma<br />
AVN Ayurveda<br />
Dr. Reddys Laboratories<br />
Emmellen Biotech<br />
Famycare<br />
Glenmark Generics<br />
Glenmark Pharmaceu cals<br />
Helvoet Pharma<br />
Hygieia Biogenics<br />
Intas Pharmaceu cals<br />
IPCA Labs<br />
Korten Pharmaceu cals<br />
Kusum Healthcare<br />
M J Biopharm<br />
Mepro Pharmaceu cals<br />
MSN Laboratories<br />
Naprod Life Sciences<br />
Novar s Enterprises<br />
Orchid Healthcare<br />
Raichem Life Sciences (Shilpa<br />
Medicare)<br />
RPG Life Sciences<br />
Sandoz<br />
Sanzyme (Formerly known as<br />
Unisankyo)<br />
Shreya Life Sciences<br />
Wincoat Colours & Coa ngs<br />
8
Key Clients: Active Pharmaceutical Ingredients<br />
Alkem Laboratories<br />
Amrutanjan Healthcare<br />
BASF Coa ng (India)<br />
Dr. Reddy’s Labs<br />
Embio<br />
Enaltec Labs<br />
Fermenta Biotech<br />
Glenmark Generics<br />
Mac-Chem<br />
Navin Flourine Interna onal<br />
Omni Ac ve Health Technologies<br />
Reliance Life Sciences<br />
RPG Life Sciences<br />
Sterling Biotech<br />
Unimark Remedies<br />
Zydus Cadilla<br />
9
Key Clients: Biopharmaceuticals<br />
Biological E.<br />
Fermenta Biotech<br />
Kasiak Labs (Part of Bharat Serums<br />
and Vaccines Group)<br />
Sanzyme (Formerly known as<br />
Unisankyo Ltd.)<br />
Tex Biosciences<br />
Key Clients: Labs, R&D and Pilot Plants<br />
Wockhardt<br />
Ivax India<br />
Janssen Cilag<br />
Lupin<br />
Mankind Pharma<br />
Merck India<br />
Novar s Healthcare<br />
Promed Research Centre<br />
Sandoz<br />
Watson India<br />
10
Case Studies<br />
Finished Dosage Forms<br />
SOLID ORAL FACILITY<br />
Glenmark Generics Ltd., Goa, India<br />
This US FDA approved facility has a total built up area of 14800 Sq.m.<br />
comprising of a utility block and main manufacturing block complete<br />
with processing areas, quality control laboratory, warehouse,<br />
personnel gowning areas and service areas for air handling units and<br />
purified water generation and distribution system. This facility was<br />
constructed in a phase-wise manner over a period of 24 months.<br />
The facility has five lines for manufacture of Tablets. Each line<br />
comprises of multiple suites for granulation, drying, blending,<br />
compression, and coating. The facility has a central packing area with<br />
provision for blister (Alu-PVC, Alu-Alu), and Bulk Packing.<br />
The construction activities during the expansions were planned in such<br />
a manner that at no time there was stoppage of production. Necessary<br />
measures to minimize the interference with the ongoing operations<br />
were adopted.<br />
SCOPE OF SERVICES:<br />
·Basic Engineering, Detail Engineering, Commissioning<br />
& Start Up<br />
SOLID ORAL & LIQUID ORAL FACILITY<br />
Aurobindo Pharmaceuticals Ltd. , Hyderabad, India<br />
This US FDA approved facility was built on a green-field site. The<br />
facility comprises of two four-storey blocks built adjacent to each<br />
other and interconnected through corridors on each floor.<br />
The total constructed area of the production blocks is 26000 sq<br />
meters inclusive of Warehouse and personnel gowning areas. The<br />
facility was built in a time span of 18 months. The blocks have<br />
manufacturing sections for three finished dosage forms viz. Tablets,<br />
Dry Powder Suspensions and Liquid Syrup Suspensions.<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering, Detail Engineering,<br />
Procurement Assistance, Site Audits, Commissioning &<br />
Start Up<br />
The manufacturing section comprise of 7 Granulation suites, 8 Tablet<br />
Compression suites, 7 Coating suites, 6 Packing lines, 1 line for Dry<br />
Syrups and 1 line for Liquid Syrups. Facility designed as a multistorey<br />
facility with intermediate flow of materials by gravity. This<br />
allows effective utilization of ground space.<br />
11
Case Studies<br />
Finished Dosage Forms<br />
SOLID ORALS & INJECTABLE FACILITY (ONCOLOGY)<br />
Shilpa Medicare Ltd. (Raichem LifeSciences), Hyderabad, India<br />
The facility is designed to meet the regulatory requirements of<br />
international bodies such as US FDA, UK MHRA, Australian TGA,<br />
Brazilian ANVISA, PMDA Japan. The entire development comprises of 7<br />
separate blocks spread over 27000 Sq.M. of plot. The structures planned<br />
include Oral Solids block, Injectable Block, R & D Block, Quality Control &<br />
Quality Assurance Block, Administration Block, Canteen, Utility Block,<br />
and other ancillaries like Security cabin, Pump rooms, ETP, etc.<br />
SCOPE OF SERVICES:<br />
Concept Design,<br />
Basic Engineering,<br />
Detailed Engineering,<br />
Containment Strategies,<br />
Procurement Assistance,<br />
Construction Management<br />
SOLID ORAL FACILITY (HORMONES)<br />
Glenmark Generics Ltd., Goa, India<br />
This US FDA approved facility was built on a green-field site and<br />
comprised of two-storey production block along with other ancillary<br />
blocks.<br />
The production block has a pilot plant and a commercial scale<br />
manufacturing section for hormones in Tablet Form. The total built up<br />
area of the is 4830 sq meters which houses pilot plant, commercial<br />
scale manufacturing section, packaging section, warehouse, personnel<br />
gowning areas, technical area for AHUs and routing of services, Quality<br />
control laboratories and administration offices.<br />
The facility was built in a time frame of 10 months. The plant was<br />
designed with a prime emphasis on product, personal & environmental<br />
safety. Layout was prepared to allow unidirectional movement of<br />
material and personnel and minimize potential mix-ups. The main<br />
manufacturing areas were maintained at negative pressure with<br />
respect to peripheral socially clean corridor.<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering, Detail Engineering,<br />
Procurement Assistance, Construction Management,<br />
Commissioning & Start Up, Validation Support<br />
12
PROJECT COVERAGE<br />
GEORGIA<br />
CONGO<br />
MALAYSIA<br />
INDONESIA<br />
Note: The locations marked are only indicative
Case Studies<br />
Finished Dosage Forms<br />
PILOT PLANT (HI-POTENT PRODUCTS)<br />
Janssen Cilag Pharmaceuticals, (Johnson & Johnson), Mumbai, India<br />
This Pilot Scale Manufacturing facility for Solids, Liquids & Ointments was set up in a time span of 20 months.<br />
The facility is designed for handling PBOEL 3B compounds. It is proposed to be one of J&J's prime facilities for handling high potent<br />
formulations. Though the facility was a green field project, the constraint was that it was set up in an existing manufacturing site of<br />
SCOPE OF SERVICES:<br />
Concept Design<br />
Basic Engineering<br />
Detail Engineering<br />
Procurement Assistance<br />
Site Audits<br />
Construction Management<br />
Commissioning & Start Up<br />
Validation Support<br />
Janssen Cilag in Mumbai. This site is<br />
located within a largely residential area of<br />
Mumbai, and there were lots of restrictions<br />
as far as usable ground space, height,<br />
environmental protection etc. were<br />
concerned.<br />
The facility consists of the following main<br />
sections Ware House, Development Lab,<br />
Pre Formulation Scale Manufacturing, Pilot<br />
Scale manufacturing. Approximate built up<br />
area of the facility is 2000 Square Meters.<br />
The facility is a Ground plus three-storied<br />
structure.<br />
LIQUID & FREEZE DRIED INJECTABLE FACILITY (ONCOLOGY)<br />
Glenmark Generics Ltd., Pilar, Argentina<br />
The facility was designed to produce Liquid and Freeze Dried Oncology<br />
Injectables. The facility was designed on a green-field site of about<br />
10000 Sq.M. The main block is designed as a two storey building with<br />
Production area, Warehouse, Personnel Gowning areas housed on the<br />
Ground Floor and the Quality Assurance and Quality Control sections<br />
housed on the First Floor.<br />
The Vial Filling line and Freeze Drier have been procured from leading<br />
manufacturers in Europe. Clean room panels, HVAC items, Hi-Purity<br />
water generation and distribution systems and other process<br />
equipments have been supplied from India to reduce the project cost.<br />
The AHUs have Bag-In Bag-Out type filter arrangement to avoid<br />
exposure of operator to potent dust while replacing the filter. The<br />
process effluents generated are first deactivated and then released into<br />
the main effluent treatment plant. The exhaust air from various systems<br />
is filtered thru ULPA filters prior to release in to the atmosphere.<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering, Detail Engineering,<br />
Procurement Assistance, Construction Management,<br />
Commissioning & Start Up, Validation Support<br />
14
Case Studies<br />
Finished Dosage Forms<br />
METERED DOSE INHALERS<br />
Glenmark Pharmaceuticals Ltd., Baddi, India<br />
The facility is designed to produce 'Metered Dose Inhalers' and<br />
has a total built up area of about 3500 Sq.M. The main block is<br />
designed as a three floor structure and houses Production<br />
area, Stores, Personnel Gowning areas and a compact Quality<br />
Control section.<br />
The MDI Filling line has been procured from DH Industries<br />
(Pamasol), UK. The line has an arrangement for single and<br />
double stage propellant filling of containers. HFA 134a will<br />
be used as propellant.<br />
<strong>SPECTRUM</strong> was involved in developing Process P&IDs<br />
including P&IDs for transfer of pressurized HFA, URS for<br />
Process Vessels and in the process has gained valuable<br />
exposure to special design requirements of such facilities. The<br />
layout is planned in a manner so as to enable modular<br />
expansion of the facility to accommodate second filling line in<br />
future.<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering, Detail<br />
Engineering, Procurement Assistance, Construction<br />
Management, Commissioning & Start Up.<br />
INSULIN INJECTABLES, ORAL SOLIDS &<br />
CEPHALOSPORINE POWDER INJECTABLE FACILITY<br />
M J Biopharm, Navi Mumbai, India<br />
SCOPE OF SERVICES:<br />
Concept Design<br />
Basic Engineering<br />
Detail Engineering<br />
Procurement Assistance<br />
Validation Support<br />
The facility was built with technical support of Eli-Lily, USA.<br />
<strong>SPECTRUM</strong>'s personnel visited US plant of Eli-Lily to understand<br />
manufacturing operations prior to design of the facility.<br />
The entire development comprises of 3 separate buildings spread<br />
over 25000 Sq.M. of plot with the main block housing manufacturing<br />
sections for Insulin Injectables. The Cephalosporine Dry Powder<br />
Injectables are produced in a dedicated block and houses its own<br />
manufacturing, warehousing and personnel gowning sections.<br />
Built in a time span of 18 months, this Facility is approved by UK<br />
MHRA, South African MCC, Brazil ANVISA.<br />
15
Case Studies<br />
Finished Dosage Forms<br />
LARGE VOLUME PARENTERALS FACILITY<br />
JSC Eastpharm, Vladivostok, Russia<br />
The project involved setting up facility for producing Large<br />
Volume Parenterals and associated testing laboratories at<br />
Vladvostok in Russia. The facility was planned in accordance to<br />
cGMP requirements of WHO.<br />
<strong>SPECTRUM</strong> was involved in sizing and selection of process<br />
Detail Engineering<br />
equipment and <strong>SPECTRUM</strong>'s scope included developing<br />
Procurement Assistance<br />
concept designs, basic engineering and detailed engineering.<br />
Construction Management<br />
Systems such as Modular Clean room panels, HVAC, Process<br />
Validation Assistance<br />
Equipment, Generation and Distribution systems for Purified<br />
Water, WFI, Pure Steam were supplied from India.<br />
Phase I of the project, has an annual installed capacity of 12 Million bottles of 500 ml fill volume whereas the Phase II of the project<br />
augmented the annual capacity by additional 8 Million bottles of 100 ml fill volume.<br />
16<br />
SVP with BFS MACHINE, PENICILLIN & CEPHALOSPORIN DRY<br />
POWDER INJECTABLES FACILITY and GENERAL ORAL SOLIDS FACILITY<br />
SCOPE OF SERVICES:<br />
Concept Design<br />
Basic Engineering<br />
Detail Engineering<br />
Procurement Assistance<br />
SCOPE OF SERVICES:<br />
Concept Design<br />
Basic Engineering<br />
JSC Pharmasyntez, Irkutsk, Russia<br />
The project involved setting up facilities for manufacturing SVP with BFS<br />
machine for Water for Injection & Opthalmic products, General Oral<br />
Solids, Penicillin Dry Powder Injectables and Cephalosporin Dry Powder<br />
Injectables. The facilities were planned in an existing building and were<br />
set up in accordance to cGMP requirements of WHO.<br />
Unique feature of engineering was design of HVAC systems for sub-zero<br />
temperatures of up to (– 40) deg.C. This required Humidification as the<br />
humidity levels would fall to very low levels during winters. Systems such<br />
as HVAC, Process Equipment, Generation and Distribution systems for<br />
Purified Water, WFI, Pure Steam were supplied from India.<br />
The project provided insight in to how project were executed in countries<br />
of erstwhile Soviet Republic. It would typically involve preparing and<br />
submitting project drawings and documents to a local project institute<br />
who were the only ones authorized to design projects in Russia. The<br />
institute would then translate all drawings in local language and then<br />
issue the same to contractors for execution.<br />
We have installed Rommelag 321 for manufacturing of ampoules for Water for Injection and ophthalmic products with BFS<br />
technology. Machine has annual output 12.0 Million with one shift a day.
Case Studies<br />
Finished Dosage Forms<br />
INJECTABLE FACILITY (HORMONES)<br />
SANZYME LTD, SHAMEERPET, HYDERABAD India<br />
SCOPE OF SERVICES:<br />
Concept Design<br />
Basic Engineering<br />
Detail Engineering<br />
Procurement Assistance<br />
Construction Management<br />
Validation Support<br />
The facility is designed to meet the regulatory<br />
requirements of international bodies such as US FDA,<br />
UK MHRA. The entire development comprises of 3<br />
separate blocks spread over 15300 Sq.M. of plot. The<br />
structures planned include Injectable Block, Bio Lab,<br />
Utility Block, and other ancillaries like Security cabin,<br />
Pump rooms, ETP, etc.<br />
The salient design features of the facility include:<br />
<br />
<br />
<br />
<br />
<br />
Combi line (Vial and Ampoule) for Hormonal Injections and with Lyophilization.<br />
Dedicated Bio Animal Lab planned in the Plot<br />
Construction of Process areas with Clean room Modular panels.<br />
Clean Utility system consists of Purified water, Water for Injection and Pure steam planned for the Injectable plant.<br />
Effluent deactivation prior to discharge to the main ETP.<br />
SOLID ORALS & INJECTABLE FACILITY (ONCOLOGY)<br />
Neapolis Pharma,Tunisia (Part of Medis Group)<br />
The facility is designed to produce Oral Solids and Liquids<br />
and Freeze Dried Injectables. The facility is designed in<br />
accordance with regulatory requirements of EU GMP.<br />
The salient design features of the facility include –<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Isolators for Active Sampling & Dispensing, Solution<br />
preparation for Injectables.<br />
Single Pot Processor Technology for Granulation.<br />
Contained transfer systems for Compression &<br />
Coating machines.<br />
Bag-in Bag-out filters for AHUs.<br />
Pre-engineered concrete building.<br />
Construction of Process areas with Clean room<br />
panels.<br />
Effluent deactivation system prior to discharge to the<br />
main ETP.<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering,<br />
Detail Engineering, Procurement<br />
Assistance, Commissioning<br />
Assistance, Validation Support<br />
17
Case Studies<br />
Finished Dosage Forms<br />
LAB and R&D FACILITY<br />
Novartis Healthcare Pvt. Ltd., Thane, India<br />
<strong>SPECTRUM</strong> designed and engineered a global research &<br />
development laboratory & pilot scale manufacturing facility for<br />
Novartis healthcare.<br />
SCOPE OF SERVICES:<br />
Project Management<br />
The main sections built in the center were:<br />
Basic Engineering<br />
Analytical Laboratory<br />
Detail Engineering<br />
Wet Chemistry Lab<br />
Procurement Assistance<br />
Pilot Plant for OSD, Liquids & Semisolids.<br />
Inspection & Expediting<br />
Stability Chambers' section<br />
Offices for Chemists<br />
Construction Management<br />
Utility Area<br />
Validation Support<br />
The Project was done in existing building. Approximate area of<br />
he facility is 12,500 Square feet. Facility was planned to<br />
accommodate 25 Chemists. All utilities such as Lab Gases & Air compressors were located on Terrace. The major constraint in the<br />
project was that the Lab was located on 5th floor & all the utilities had to pass through the 6th floor to reach the Labs.This project was<br />
completed in record time of 10 Months and was appreciated as a state of the art facility & was qualified by Novartis, Switzerland's<br />
Quality Control Department<br />
MULTIPLE DOSAGE FORMULATION FACILITY<br />
Ethiopian Pharmaceuticals Ltd., Addis Ababa, Ethiopia<br />
Ethiopian Pharmaceutical Manufacturing (EPHARM), fully owned by national government of Ethiopia, is the largest manufacturer<br />
of Finished Dosage Formulations in Ethiopia. Epharm was planning to set up new manufacturing facilities in accordance with<br />
cGMP requirements of WHO and had a requirement of carrying out Project Feasibility study before the initiative was taken further.<br />
SCOPE OF SERVICES:<br />
Capacity Planning, Conceptual Design, Basic Engineering ,<br />
Project Costing, Project Implementation Strategy<br />
18<br />
<strong>SPECTRUM</strong> partnered with Industrial Project Services (IPS) of Ethiopia<br />
to conduct this study. <strong>SPECTRUM</strong>'s scope comprised of Capacity<br />
Planning for all dosage forms based on Market Study reports and<br />
Category of Products proposed by IPS. This was followed by sizing of<br />
Production batches, recommending equipment capacities and preparing<br />
facility layouts in accordance with GMP. The final capacities and facility<br />
sizes were again reviewed based on the feasibility of accommodating<br />
these blocks in the piece of land already available with Epharm.<br />
The facilities or structures planned included Oral Solids Block for<br />
General Products, Penicillin Block, Large Volume Parenteral Block, Oral<br />
Liquids and Suspensions Block, Cephalosporin Block and Dermatology<br />
formulation block. In addition to this a Central Warehouse,<br />
Administration, Quality Control, Quality Assurance, R & D and Utility<br />
Blocks were also planned. The total planned built up area was about<br />
55,000 Sq. M.
Case Studies<br />
Finished Dosage Forms<br />
SCOPE OF SERVICES:<br />
Project Management<br />
Basic Engineering<br />
Detail Engineering<br />
Procurement Assistance<br />
Inspection & Expediting<br />
Construction Management<br />
Validation Support<br />
RUBBER COMPOUNDS PRODUCING FACILITY<br />
Helvoet Pharma India Operation Pvt. Ltd., Near Pune, India<br />
Helvoet Pharma, a Belgium based enterprise and part of the<br />
Datwyler Group is one of the leading producers of Packaging<br />
products for the Pharmaceutical industry in the world. This is<br />
their first manufacturing plant in India.<br />
The facility produces rubber components in the form of<br />
Closures to be used in the Pharmaceutical industry. The facility<br />
has sections for Rubber Mixing, Milling, Extrusion, Moulding,<br />
Trimming, Washing and Packaging. Since the product being<br />
produced was meant for use in pharmaceutical applications,<br />
the environment in the washing sections of the facility were<br />
classified and maintained in line with the cGMP standards<br />
prevalent in the Pharmaceutical industry. The process water used in the final stages of washing of the components met the USP<br />
standard of Purified Water and Water for Injection. In addition there were storage areas for Raw Materials, Packaging Material,<br />
Finished products and Solvents, Quality Control laboratory, Administration offices, Maintenance areas, etc.<br />
SOLID ORALS & INJECTABLE FACILITY (ONCOLOGY)<br />
Naprod Life Sciences Pvt. Ltd., Tarapur, India<br />
The facility comprised of a compact manufacturing block<br />
with Dispensing and Manufacturing areas admeasuring<br />
only 1000 Sq.M. The facility has received ANVISA<br />
approval.<br />
The production block has manufacturing sections for<br />
Freeze-Dried Injectables and Oral Solids in the form of<br />
Tablets and Capsules.<br />
Dispensing of Actives and Solution Compounding for<br />
Injectables is done inside Isolators. Personnel Protective<br />
Gowns are planned for personnel working in other parts of<br />
the manufacturing areas where they handle potent<br />
material. The main manufacturing areas were maintained<br />
at negative pressure with respect to peripheral socially<br />
clean corridor. The process effluents generated are first<br />
deactivated and then released into the main effluent<br />
treatment plant.<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering, Detail Engineering,<br />
Validation Support<br />
19
Case Studies<br />
Finished Dosage Forms<br />
PHARMA CLUSTER<br />
JSC Humanity, Tbilisi, Georgia<br />
The ongoing facility is designed to meet the regulatory requirements of<br />
international bodies such as EU GMP.<br />
The entire development comprises of 9 separate blocks with total built up<br />
area of 29000 Sq. Mtr. Facility has been planned in existing structures.<br />
The structures planned include Repackaging for General products,<br />
Repackaging for Oncology and Hormone products, Repackaging of<br />
Cephalosporin products, Full manufacturing for Oral solid dosage form,<br />
Central warehouse, Central Quality control laboratory, and<br />
Administration & QA, Utility and HT yard. The projected cost of the entire<br />
development is USD 30 Million.<br />
The salient design features of the facility include:<br />
Pre-Engineered Metal Building construction for the new buildings of<br />
Full line Oral solid dosage form for faster construction.<br />
Central warehouse is planned for storage of 10,000 pallets with selfsupported<br />
ASRS.<br />
Existing structures are refurbished to meet the GMP requirement.<br />
Construction of Process areas with Clean room panels.<br />
Effluent deactivation prior to discharge to the main ETP. .<br />
SCOPE OF SERVICES:<br />
Master Planning, Concept Design, Basic Engineering,<br />
Detail Engineering, Procurement Assistance,<br />
Construction Management, Validation Documentation,<br />
QMS Development & Implementation<br />
SOLID ORAL FORMULATION FACILITY<br />
Pharmax pharmaceuticals, Dubai, UAE<br />
The Facility is designed for manufacturing Oral Solid Dosage<br />
formulations under General category with plans to expand and set up<br />
facilities for the other pharmaceutical dosages in near future. The<br />
Facility is planned in plot of approx. 8715.60 Sq. M. in the industrial<br />
area at Duboitech, Dubai. The facility is designed in compliance with<br />
requirements of the various local authorities like DEWA, DM, and<br />
DCDA, etc and designed to meet cGMP requirements of regulatory<br />
bodies like US FDA, EU and GCC.<br />
SCOPE OF SERVICES:<br />
Master Planning, Conceptual Design, Basic Engineering ,<br />
Detail engineering, procurement assistance, Commissioning<br />
assistance, Documentation & validation Support<br />
When fully operational, this Oral Solid Dosage facility will be capable<br />
of producing 195 million tablets per year & 10 million Capsules (Hard<br />
Gelatine) per year.<br />
The core areas are planned in Modular Panels. The Cooling system is<br />
designed considering the District Cooling system.<br />
20
Case Studies<br />
Finished Dosage Forms<br />
ONCOLOGY OSD & GENERAL OSD FACILITY<br />
Novast Laboratories Ltd., Nantong, China<br />
The project comprises of two separate blocks for producing Oral Solid<br />
Dosage formulations for General and Oncology category of products.<br />
The planned annual capacity of the General products facility is about<br />
2 billion units and that of Oncology products facility is about 70 million<br />
units. The facility has been set up in accordance with regulatory<br />
guidelines of US FDA and other local statutory norms for safety and<br />
building construction regulation.<br />
SCOPE OF SERVICES:<br />
Concept Design, Containment Strategy (For Oncology Facility),<br />
Basic Engineering, Detail Engineering, Procurement Assistance<br />
(For Oncology Facility Process Equipment), Construction<br />
Supervision, Documentation & Validation Support<br />
The Oncology facility has its dedicated Store and Quality Control<br />
departments whereas the General products facility shares these<br />
services with the other existing blocks.<br />
Spectrum on this project worked in coordination with a local design<br />
firm, who supported in development of Structural and Fire Safety<br />
designs as per local codes and supported Novast in applying and<br />
getting required statutory approvals.<br />
VACCINE FILL FINISH FACILITY<br />
A.J. Biologics, Malaysia<br />
This is the first Vaccine production facility coming up in<br />
Malaysia. The proposed facility will be planned, designed,<br />
engineered and operated as per current cGMP standards<br />
of international regulatory authorities of EMEA, PIC/S as<br />
well as conform to all local regulatory requirements.<br />
The facility will be designed to produce liquid injectable in<br />
vials and pre-filled syringes and lyophilised injectable in<br />
vials. The facility will be capable of producing 12.5 million<br />
vials per year of liquid injections, 10 million vials per year of<br />
lyophilised injections and 10 million syringes per year of<br />
liquids in pre-filled syringes.<br />
The facility will also have proper storage units for raw<br />
materials, finished product storage prior to shipment and<br />
other spares and consumables. A proper laboratory<br />
system is also planned to allow quality assurance, quality<br />
control and in-process quality control activities to be<br />
conducted as per regulatory guidelines.<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering, Detail Engineering,<br />
Procurement Assistance, Project Management, Site Supervision,<br />
Commissioning & Startups, Documentation & Validation Support<br />
21
Case Studies<br />
Biopharmaceuticals<br />
SCOPE OF SERVICES:<br />
Project Management<br />
Basic Engineering<br />
Detailed Engineering<br />
Procurement Assistance<br />
ANIMAL FEED ENZYME PRODUCTION FACILITY<br />
TexBioscience Pvt. Ltd., Chennai, India.<br />
TexBioscience is one of the leading producers of enzymes<br />
and has production facilities for textile and animal feed<br />
enzyme.<br />
The facility will be designed as multi-purpose facility to<br />
facilitate manufacturing of animal feed enzymes based on<br />
bacterial and fungal culture. The facility will be designed to<br />
meet HACCP guidelines applicable for Animal feed<br />
manufacturing.<br />
The facility has two separate culture development and<br />
fermentation sections, one each for Fungal and Bacterial<br />
fermentation. There are two 20 KL production fermenters in<br />
each module. The downstream processing involves<br />
Harvesting, Filter Press, Centrifuge as one line and Microfiltration and Spray Drying as the other line. The final enzyme is blended with<br />
diluent and packed.<br />
VACCINE PRODUCTION FACILITY<br />
BIOLOGICAL E. LTD., Hyderabad, India.<br />
Biological E. was established over 50 years ago. It is the first private sector biological products company in India and the first<br />
pharmaceuticals company in South India. BE is also the pioneer in preventive medicine.<br />
The facility will be designed as multi-purpose facility to facilitate manufacturing of bulk vaccines on campaign basis. The facility will be<br />
designed for 100 million doses/ year of each bulk vaccine under cGMP conditions. Required unit operations such as cell propagation,<br />
incubation, Virus infection, virus incubation, harvesting, Media preparation and storage.<br />
The facility will be designed in accordance of containment requirement for managing infectious agents of BSL 2 category. The design<br />
objective is to protect the operators and others from exposure and also to protect the outside environment from potentially<br />
hazardous/infectious agents.<br />
SCOPE OF SERVICES:<br />
Project Management, Basic Engineering , Detailed Engineering, Procurement Assistance, Validation Support<br />
22
Case Studies<br />
Biopharmaceuticals<br />
FERMENTATION FACILITY<br />
Sanzyme Ltd.,Near Hyderabad, India<br />
SCOPE OF SERVICES:<br />
Basic Engineering<br />
Detail Engineering<br />
Procurement Assistance<br />
Site Supervision Support<br />
Validation Support<br />
The facility produces various types of Probiotics. The facility<br />
is designed to meet the internal standards and international<br />
regulatory requirements. Two dedicated blocks one for<br />
probiotic and one for Lactic acid bacillus (LAB block) were<br />
planned in the plot. In addition there block specific areas for<br />
Raw Materials, Packaging Material, Finished products and<br />
Solvents. The support infrastructure such as Quality Control<br />
laboratory, Administration offices, Maintenance areas, ETP,<br />
Utility block, etc. are common for both the block.<br />
INSULIN PRODUCTION FACILITY<br />
Wockhardt. Ltd., Aurangabad, India.<br />
Wockhardt Ltd is one of the leading Pharmaceutical and<br />
Biotech manufacturer in India and also has manufacturing<br />
facilities in US and UK. This facility was the expansion of<br />
their existing facility named as “Plant D, Phase-I”.<br />
The process involved for the LAB block includes<br />
fermentation, separation, drying (Spray drier) and powder<br />
processing. Powder processing area is designed as clean room and having control and monitoring of air as per ISO 8 requirement for<br />
HVAC system.Purified water as per USP grade was installed and was used for cleaning and rinsing of production equipment.<br />
Fermenters, three in numbers of 25KL each were installed in LAB block.<br />
The proposed facility was planned, designed and<br />
engineered as per cGMP standards and shall confirm to all<br />
relevant local statuary/regulatory and c G M P<br />
requirements. The design was done considering phase-II<br />
& phase-III expansions in future. The facility has two sets<br />
of 20 KL, 2KL, 0.2KL & 0.02 KL fermenters & 2 Nos. of 7<br />
KL Harvesters. The layout was planned as G+2 structure<br />
with service area on terrace. Modular & Aerocon panels<br />
were used on all the floors to ease dismantling and<br />
expansion of facility. The utility equipment's were located<br />
on terrace to reduce on pumping energy & associated<br />
piping inventory.<br />
SCOPE OF SERVICES:<br />
Review of Conceptual Design, Basic Engineering , Detail<br />
Engineering, Procurement Assistance, Validation Support<br />
23
Case Studies<br />
Active Pharmaceutical Ingredients<br />
CEPHALOSPORIN CRYSTALLINE STERILE BULK FACILITY<br />
Parabolic Drugs Limited, Derabassi, Punjab.<br />
The facility is designed to produce<br />
'Cephalosporin Crystalline Sterile Bulk' and<br />
has a total built up area of about 1600 Sq.M.<br />
The main block is designed as a ground plus<br />
two storey structure with warehouse and<br />
production area on Ground floor, Technical<br />
area for placement of AHU on first floor and<br />
Utility area on second floor<br />
SCOPE OF SERVICES:<br />
Concept Design, Basic Engineering, Detail Engineering,<br />
Procurement Assistance,<br />
The operations carried out in the sterile area<br />
i.e. from crystallization step onwards thru to<br />
Drying, Filling and Packing is fully<br />
automated and is procured from Omca<br />
Plants Srl. (BA.DO.), Italy.<br />
MULTI PRODUCT SMALL SCALE PRODUCTION & KILO LAB FACILTY<br />
Enaltec Labs, Ambernath, India<br />
The facility was designed as a Multi-Product Small Scale<br />
Production & Kilo Lab facility for manufacturing APIs.<br />
The proposed facility was planned, designed and engineered as<br />
per cGMP standards of international authorities like USFDA,<br />
WHO etc. and confirms to all relevant local statuary/regulatory<br />
and cGMP requirements. The facility design complies with ICH,<br />
NFPA & ISPE guidelines. The facility has eventually received<br />
approval by USFDA.<br />
The project comprised of setting up of Production Block,<br />
Warehouse & Quality Control Block. In addition, the facility has<br />
all necessary ancillary structures like Utility Block, Solvent Drum<br />
Yard, Transformer Yard and Effluent treatment plant.<br />
SCOPE OF SERVICES:<br />
Basic Engineering , Detail Engineering, Procurement<br />
Assistance, Inspection & Expediting, Construction<br />
Management, Validation Support<br />
24
Case Studies<br />
Active Pharmaceutical Ingredients<br />
VITAMIN D3 & ALLIED PRODUCTS FACILITY<br />
Fermenta Biotech, Dahej, India<br />
The scope commenced with Site Master<br />
Planning for setting up of blocks for all<br />
production stages of Vitamin D3, in phases.<br />
The entire project was envisioned to be<br />
developed in four phases commencing with<br />
setting up of API facility in the first phase<br />
with backward integration to Fermentation<br />
facility in the fourth phase.<br />
The overall site to be developed is about<br />
28,000 Sq.M with a total constructed area<br />
of 3000 Sq.M in the first phase. The first<br />
phase of the project was completed in 12<br />
months.<br />
SCOPE OF SERVICES:<br />
Master Planning, Basic Engineering, Detail Engineering, Procurement<br />
Assistance, Site Audits, Construction Management, Commissioning & Start<br />
Up , Validation Support<br />
API FACILITY (HORMONE)<br />
Dr. Reddy's Laboratories (DRL), Vizag, India<br />
The Hormone Manufacturing facility was constructed on an existing<br />
site of DRL. Area of production block is approx. 1500 Sq.M with a<br />
capacity of 50 Kgs/ month. The project cost was completed in 10<br />
months.<br />
The facility has two dedicated self-contained modules for<br />
manufacturing two products simultaneously. The facility was design<br />
for PBOEL (Performance Based Operator Exposure Limit) of 500<br />
ng/cu.m. Based on this risk assessment Containment levels were<br />
decided. Dedicated detoxification reactor is provided to detoxify the<br />
effluent before discharging it to a common Effluent Treatment Plant.<br />
SCOPE OF SERVICES:<br />
Concept Design , Basic Engineering, Detail Engineering,<br />
Procurement Assistance, Site Supervision, Commissioning &<br />
Start up, Validation & Documentation Support<br />
<strong>SPECTRUM</strong> provided critical inputs during planning stage to<br />
minimize handling of potent product in powder form. The risk<br />
elimination at source technique was used minimizing operator<br />
interface. This facility has been approved by USFDA.<br />
25
Spectrum PharmaTECH<br />
Consultants Pvt. Ltd.<br />
Address:<br />
503, Dosti Pinnacle<br />
Plot E-7, Road No. 22, Wagle Estate<br />
Thane (West)- 400607, India<br />
Tel: +91-22-21580500, Fax: +91-22-21580505<br />
E-mail: engg@spectrumpharmatech.com<br />
Web Site: www.spectrumpharmatech.com